메뉴 건너뛰기




Volumn 251, Issue 1, 2007, Pages 146-157

Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model

Author keywords

c FLIP(L); DR5; Lexatumumab; Metastasis; Orthotopic; Renal cell carcinoma; TRAIL

Indexed keywords

CANCER VACCINE; CASPASE 8; CASPASE 9; DEATH RECEPTOR 5; FLICE INHIBITORY PROTEIN; LEXATUMUMAB; MONOCLONAL ANTIBODY; SORAFENIB; SUNITINIB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

EID: 34247145009     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.013     Document Type: Article
Times cited : (43)

References (49)
  • 1
    • 27744561283 scopus 로고    scopus 로고
    • Renal cell carcinoma: current status and future prospects
    • Drucker B.J. Renal cell carcinoma: current status and future prospects. Cancer Treat. Rev. 31 (2005) 536-545
    • (2005) Cancer Treat. Rev. , vol.31 , pp. 536-545
    • Drucker, B.J.1
  • 3
    • 0036606414 scopus 로고    scopus 로고
    • Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma
    • Griffith T.S., Fialkov J.M., Scott D.L., Azuhata T., Williams R.D., Wall N.R., Altieri D.C., and Sandler A.D. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res. 62 (2002) 3093-3099
    • (2002) Cancer Res. , vol.62 , pp. 3093-3099
    • Griffith, T.S.1    Fialkov, J.M.2    Scott, D.L.3    Azuhata, T.4    Williams, R.D.5    Wall, N.R.6    Altieri, D.C.7    Sandler, A.D.8
  • 7
    • 0033662433 scopus 로고    scopus 로고
    • Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5
    • Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., and Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12 (2000) 611-620
    • (2000) Immunity , vol.12 , pp. 611-620
    • Kischkel, F.C.1    Lawrence, D.A.2    Chuntharapai, A.3    Schow, P.4    Kim, K.J.5    Ashkenazi, A.6
  • 8
    • 0033667778 scopus 로고    scopus 로고
    • FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
    • Sprick M.R., Weigand M.A., Rieser E., Rauch C.T., Juo P., Blenis J., Krammer P.H., and Walczak H. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12 (2000) 599-609
    • (2000) Immunity , vol.12 , pp. 599-609
    • Sprick, M.R.1    Weigand, M.A.2    Rieser, E.3    Rauch, C.T.4    Juo, P.5    Blenis, J.6    Krammer, P.H.7    Walczak, H.8
  • 10
    • 25144433291 scopus 로고    scopus 로고
    • Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer
    • Zhang X., Cheung R.M., Komaki R., Fang B., and Chang J.Y. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin. Cancer Res. 11 (2005) 6657-6668
    • (2005) Clin. Cancer Res. , vol.11 , pp. 6657-6668
    • Zhang, X.1    Cheung, R.M.2    Komaki, R.3    Fang, B.4    Chang, J.Y.5
  • 11
    • 0030762815 scopus 로고    scopus 로고
    • An antagonist decoy receptor and a death domain-containing receptor for TRAIL
    • Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
    • (1997) Science , vol.277 , pp. 815-818
    • Pan, G.1    Ni, J.2    Wei, Y.F.3    Yu, G.4    Gentz, R.5    Dixit, V.M.6
  • 12
    • 0035912060 scopus 로고    scopus 로고
    • Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways
    • Suliman A., Lam A., Datta R., and Srivastava R.K. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20 (2001) 2122-2133
    • (2001) Oncogene , vol.20 , pp. 2122-2133
    • Suliman, A.1    Lam, A.2    Datta, R.3    Srivastava, R.K.4
  • 13
    • 27644543263 scopus 로고    scopus 로고
    • Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2
    • Sinicrope F.A., and Penington R.C. Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2. Mol. Cancer Ther. 4 (2005) 1475-1483
    • (2005) Mol. Cancer Ther. , vol.4 , pp. 1475-1483
    • Sinicrope, F.A.1    Penington, R.C.2
  • 15
    • 33344471933 scopus 로고    scopus 로고
    • Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells
    • Flahaut M., Muhlethaler-Mottet A., Auderset K., Bourloud K.B., Meier R., Popovic M.B., Joseph J.M., and Gross N. Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. Apoptosis 11 (2006) 255-263
    • (2006) Apoptosis , vol.11 , pp. 255-263
    • Flahaut, M.1    Muhlethaler-Mottet, A.2    Auderset, K.3    Bourloud, K.B.4    Meier, R.5    Popovic, M.B.6    Joseph, J.M.7    Gross, N.8
  • 16
    • 30344452318 scopus 로고    scopus 로고
    • Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP
    • Galligan L., Longley D.B., McEwan M., Wilson T.R., McLaughlin K., and Johnston P.G. Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol. Cancer Ther. 4 (2005) 2026-2036
    • (2005) Mol. Cancer Ther. , vol.4 , pp. 2026-2036
    • Galligan, L.1    Longley, D.B.2    McEwan, M.3    Wilson, T.R.4    McLaughlin, K.5    Johnston, P.G.6
  • 18
    • 0242656497 scopus 로고    scopus 로고
    • Death receptor-induced cell killing
    • Thorburn A. Death receptor-induced cell killing. Cell Signal. 16 (2004) 139-144
    • (2004) Cell Signal. , vol.16 , pp. 139-144
    • Thorburn, A.1
  • 20
    • 32944475745 scopus 로고    scopus 로고
    • Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5
    • Kim H., Kim E.H., Eom Y.W., Kim W.H., Kwon T.K., Lee S.J., and Choi K.S. Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5. Cancer Res. 66 (2006) 1740-1750
    • (2006) Cancer Res. , vol.66 , pp. 1740-1750
    • Kim, H.1    Kim, E.H.2    Eom, Y.W.3    Kim, W.H.4    Kwon, T.K.5    Lee, S.J.6    Choi, K.S.7
  • 22
    • 4944248109 scopus 로고    scopus 로고
    • Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
    • Zhang X., Jin T.G., Yang H., DeWolf W.C., Khosravi-Far R., and Olumi A.F. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res. 64 (2004) 7086-7091
    • (2004) Cancer Res. , vol.64 , pp. 7086-7091
    • Zhang, X.1    Jin, T.G.2    Yang, H.3    DeWolf, W.C.4    Khosravi-Far, R.5    Olumi, A.F.6
  • 24
    • 2942526515 scopus 로고    scopus 로고
    • The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice
    • Shankar S., Singh T.R., Chen X., Thakkar H., Firnin J., and Srivastava R.K. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice. Int. J. Oncol. 24 (2004) 1133-1140
    • (2004) Int. J. Oncol. , vol.24 , pp. 1133-1140
    • Shankar, S.1    Singh, T.R.2    Chen, X.3    Thakkar, H.4    Firnin, J.5    Srivastava, R.K.6
  • 25
    • 0041633807 scopus 로고    scopus 로고
    • Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11
    • Ray S., and Almasan A. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Cancer Res. 63 (2003) 4713-4723
    • (2003) Cancer Res. , vol.63 , pp. 4713-4723
    • Ray, S.1    Almasan, A.2
  • 26
    • 13144297792 scopus 로고    scopus 로고
    • Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
    • El-Zawahry A., McKillop J., and Voelkel-Johnson C. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer 5 (2005) 2
    • (2005) BMC Cancer , vol.5 , pp. 2
    • El-Zawahry, A.1    McKillop, J.2    Voelkel-Johnson, C.3
  • 27
    • 6944247634 scopus 로고    scopus 로고
    • Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice
    • Xiang H., Nguyen C.B., Kelley S.K., Dybdal N., and Escandon E. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice. Drug. Metab. Dispos. 32 (2004) 1230-1238
    • (2004) Drug. Metab. Dispos. , vol.32 , pp. 1230-1238
    • Xiang, H.1    Nguyen, C.B.2    Kelley, S.K.3    Dybdal, N.4    Escandon, E.5
  • 28
    • 16444381759 scopus 로고    scopus 로고
    • Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice
    • Shi J., Zheng D., Liu Y., Sham M.H., Tam P., Farzaneh F., and Xu R. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice. Cancer Res. 65 (2005) 1687-1692
    • (2005) Cancer Res. , vol.65 , pp. 1687-1692
    • Shi, J.1    Zheng, D.2    Liu, Y.3    Sham, M.H.4    Tam, P.5    Farzaneh, F.6    Xu, R.7
  • 30
    • 33747829837 scopus 로고    scopus 로고
    • Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo
    • Marini P., Denzinger S., Schiller D., Kauder S., Welz S., Humphreys R., Daniel P.T., Jendrossek V., Budach W., and Belka C. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo. Oncogene 25 (2006) 5145-5154
    • (2006) Oncogene , vol.25 , pp. 5145-5154
    • Marini, P.1    Denzinger, S.2    Schiller, D.3    Kauder, S.4    Welz, S.5    Humphreys, R.6    Daniel, P.T.7    Jendrossek, V.8    Budach, W.9    Belka, C.10
  • 31
    • 0025033870 scopus 로고
    • Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]
    • Fidler I.J., Naito S., and Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]. Cancer Metastasis Rev. 9 (1990) 149-165
    • (1990) Cancer Metastasis Rev. , vol.9 , pp. 149-165
    • Fidler, I.J.1    Naito, S.2    Pathak, S.3
  • 32
    • 0024588778 scopus 로고
    • In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice
    • Naito S., Walker S.M., and Fidler I.J. In vivo selection of human renal cell carcinoma cells with high metastatic potential in nude mice. Clin. Exp. Metastasis 7 (1989) 381-389
    • (1989) Clin. Exp. Metastasis , vol.7 , pp. 381-389
    • Naito, S.1    Walker, S.M.2    Fidler, I.J.3
  • 33
    • 0027934194 scopus 로고
    • Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
    • Singh R.K., Bucana C.D., Gutman M., Fan D., Wilson M.R., and Fidler I.J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am. J. Pathol. 145 (1994) 365-374
    • (1994) Am. J. Pathol. , vol.145 , pp. 365-374
    • Singh, R.K.1    Bucana, C.D.2    Gutman, M.3    Fan, D.4    Wilson, M.R.5    Fidler, I.J.6
  • 34
    • 24944458177 scopus 로고    scopus 로고
    • Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death
    • Georgakis G.V., Li Y., Humphreys R., Andreeff M., O'Brien S., Younes M., Carbone A., Albert V., and Younes A. Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Br. J. Haematol. 130 (2005) 501-510
    • (2005) Br. J. Haematol. , vol.130 , pp. 501-510
    • Georgakis, G.V.1    Li, Y.2    Humphreys, R.3    Andreeff, M.4    O'Brien, S.5    Younes, M.6    Carbone, A.7    Albert, V.8    Younes, A.9
  • 35
    • 32444446274 scopus 로고    scopus 로고
    • Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma
    • Younes M., Georgakis G.V., Rahmani M., Beer D., and Younes A. Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma. Eur. J. Cancer 42 (2006) 542-547
    • (2006) Eur. J. Cancer , vol.42 , pp. 542-547
    • Younes, M.1    Georgakis, G.V.2    Rahmani, M.3    Beer, D.4    Younes, A.5
  • 36
    • 33646403907 scopus 로고    scopus 로고
    • Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo
    • Zeng Y., Wu X.X., Fiscella M., Shimada O., Humphreys R., Albert V., and Kakehi Y. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo. Int. J. Oncol. 28 (2006) 421-430
    • (2006) Int. J. Oncol. , vol.28 , pp. 421-430
    • Zeng, Y.1    Wu, X.X.2    Fiscella, M.3    Shimada, O.4    Humphreys, R.5    Albert, V.6    Kakehi, Y.7
  • 37
    • 17444404554 scopus 로고    scopus 로고
    • Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis
    • Brooks A.D., and Sayers T.J. Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis. Cancer Immunol. Immunother. 54 (2005) 499-505
    • (2005) Cancer Immunol. Immunother. , vol.54 , pp. 499-505
    • Brooks, A.D.1    Sayers, T.J.2
  • 38
    • 0035476255 scopus 로고    scopus 로고
    • Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria
    • Zhang X.D., Zhang X.Y., Gray C.P., Nguyen T., and Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Cancer Res. 61 (2001) 7339-7348
    • (2001) Cancer Res. , vol.61 , pp. 7339-7348
    • Zhang, X.D.1    Zhang, X.Y.2    Gray, C.P.3    Nguyen, T.4    Hersey, P.5
  • 39
    • 0037100434 scopus 로고    scopus 로고
    • IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis
    • Chawla-Sarkar M., Leaman D.W., Jacobs B.S., and Borden E.C. IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis. J. Immunol. 169 (2002) 847-855
    • (2002) J. Immunol. , vol.169 , pp. 847-855
    • Chawla-Sarkar, M.1    Leaman, D.W.2    Jacobs, B.S.3    Borden, E.C.4
  • 40
    • 0035851189 scopus 로고    scopus 로고
    • Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach
    • Burns T.F., and El-Deiry W.S. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J. Biol. Chem. 276 (2001) 37879-37886
    • (2001) J. Biol. Chem. , vol.276 , pp. 37879-37886
    • Burns, T.F.1    El-Deiry, W.S.2
  • 42
    • 12544255082 scopus 로고    scopus 로고
    • Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
    • Kelley R.F., Totpal K., Lindstrom S.H., Mathieu M., Billeci K., Deforge L., Pai R., Hymowitz S.G., and Ashkenazi A. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling. J. Biol. Chem. 280 (2005) 2205-2212
    • (2005) J. Biol. Chem. , vol.280 , pp. 2205-2212
    • Kelley, R.F.1    Totpal, K.2    Lindstrom, S.H.3    Mathieu, M.4    Billeci, K.5    Deforge, L.6    Pai, R.7    Hymowitz, S.G.8    Ashkenazi, A.9
  • 44
    • 27944483706 scopus 로고    scopus 로고
    • Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma
    • Kondo K., Yamasaki S., Sugie T., Teratani N., Kan T., Imamura M., and Shimada Y. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma. Int. J. Cancer 118 (2006) 230-242
    • (2006) Int. J. Cancer , vol.118 , pp. 230-242
    • Kondo, K.1    Yamasaki, S.2    Sugie, T.3    Teratani, N.4    Kan, T.5    Imamura, M.6    Shimada, Y.7
  • 45
    • 0032522463 scopus 로고    scopus 로고
    • p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha
    • Sheikh M.S., Burns T.F., Huang Y., Wu G.S., Amundson S., Brooks K.S., Fornace Jr. A.J., and el-Deiry W.S. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58 (1998) 1593-1598
    • (1998) Cancer Res. , vol.58 , pp. 1593-1598
    • Sheikh, M.S.1    Burns, T.F.2    Huang, Y.3    Wu, G.S.4    Amundson, S.5    Brooks, K.S.6    Fornace Jr., A.J.7    el-Deiry, W.S.8
  • 46
    • 0033989422 scopus 로고    scopus 로고
    • Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL
    • Gibson S.B., Oyer R., Spalding A.C., Anderson S.M., and Johnson G.L. Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol. Cell Biol. 20 (2000) 205-212
    • (2000) Mol. Cell Biol. , vol.20 , pp. 205-212
    • Gibson, S.B.1    Oyer, R.2    Spalding, A.C.3    Anderson, S.M.4    Johnson, G.L.5
  • 47
    • 0035863523 scopus 로고    scopus 로고
    • Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels
    • Nimmanapalli R., Perkins C.L., Orlando M., O'Bryan E., Nguyen D., and Bhalla K.N. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res. 61 (2001) 759-763
    • (2001) Cancer Res. , vol.61 , pp. 759-763
    • Nimmanapalli, R.1    Perkins, C.L.2    Orlando, M.3    O'Bryan, E.4    Nguyen, D.5    Bhalla, K.N.6
  • 49
    • 33745228422 scopus 로고    scopus 로고
    • Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5
    • Frese S., Frese-Schaper M., Andres A.C., Miescher D., Zumkehr B., and Schmid R.A. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5. Cancer Res. 66 (2006) 5867-5874
    • (2006) Cancer Res. , vol.66 , pp. 5867-5874
    • Frese, S.1    Frese-Schaper, M.2    Andres, A.C.3    Miescher, D.4    Zumkehr, B.5    Schmid, R.A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.